Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-21-001430
Filing Date
2021-02-16
Accepted
2021-02-16 16:25:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 LEAP THERAPEUTICS, INC. p21-0640sc13g.htm SC 13G 41878
  Complete submission text file 0000902664-21-001430.txt   43670
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Subject) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90188 | Film No.: 21639051
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DMS HOUSE, 20 GENESIS CLOSE PO BOX 2587 GEORGE TOWN, GRAND CAYMAN E9 KY1-1103
Business Address C/O DMS HOUSE, 20 GENESIS CLOSE PO BOX 2587 GEORGE TOWN, GRAND CAYMAN E9 KY1-1103 (345) 749-8643
HILLHOUSE CAPITAL ADVISORS, LTD. (Filed by) CIK: 0001762304 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G